BPG is committed to discovery and dissemination of knowledge
Brief Reports
©The Author(s) 2005.
World J Gastroenterol. Jul 28, 2005; 11(28): 4435-4438
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4435
Table 2 Effect of SASP on mucosal gland lesions n (%)
nGlandular abnormalityEpithelial cell regenerationAtypical hyperplasiaGCDPCM
Before treatment (mild)5617 (30.4)19 (34.0)8 (14.3)3 (5.4)0 (0)
After treatment (mild)466 (13.0)13 (28.3)2 (4.4)2 (4.4)1 (2.2)
Before treatment (moderate)5021 (42.0)15 (30.0)15 (30.0)12 (24)2 (4.0)
After treatment (moderate)4518 (40.0)7 (15.6)8 (17.8)6 (13.3)0 (0)


Write to the Help Desk